Chufei Xie
Overview
Explore the profile of Chufei Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie C, Chan L, Pang Y, Shang Y, Wang W, Zhao L
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Feb;
PMID: 39998626
Breast cancer is the most common malignant tumor in women. Among its subtypes, triple-negative breast cancer (TNBC) is more aggressive and poses a serious threat to women's health. Rosmarinic acid...
2.
Xie C, Chan L, Pang Y, Shang Y, Cao W, Tuohan M, et al.
Biomed Pharmacother
. 2024 Jul;
178:117158.
PMID: 39042963
Triple-negative breast cancer (TNBC) still one of the most challenging sub-type in breast cancer clinical. Caffeic acid (CA) derived from effective components of traditional Chinese herbal medicine has been show...
3.
Ma J, Pang Y, Shang Y, Xie C, Xu X, Chan L, et al.
Clin Immunol
. 2024 Apr;
263:110227.
PMID: 38643891
T-DM1 (Trastuzumab Emtansine) belongs to class of Antibody-Drug Conjugates (ADC), where cytotoxic drugs are conjugated with the antibody Trastuzumab to specifically target HER2-positive cancer cells. Platelets, as vital components of...
4.
Xie J, Tang X, Xie C, Wang Y, Huang J, Jin J, et al.
Genomics
. 2023 Jan;
115(2):110557.
PMID: 36610559
Early bolting of Peucedanum praeruptorum Dunn severely affects its quality. In this study, we compared with the root structure of P. praeruptorum and its four coumarins content between early bolting...